Dublin, March 14, 2025 (GLOBE NEWSWIRE) — The “Clinical Trial Supply & Logistics Market by Services, Sourcing Model, Type, Mode of Delivery, End-user, Therapeutic Area, Phases of Clinical Trials – Global Forecast 2025-2030” report has been added to ResearchAndMarkets.com’s offering.
The Clinical Trial Supply & Logistics Market grew from USD 24.33 billion in 2023 to USD 26.20 billion in 2024. It is expected to continue growing at a CAGR of 7.75%, reaching USD 41.04 billion by 2030.
The landscape of clinical trial supply and logistics has undergone unprecedented transformations. Over the past few years, the industry has seen a marked shift towards integrating digital technology and automation across multiple operational layers. Strategic moves to incorporate real-time tracking and transparency have ensured that supply chains are more agile, responsive, and capable of handling the intricacies of a global clinical operations network.
Digital transformations have spurred developments such as advanced inventory management systems and proactive risk mitigation strategies. Changes in regulations worldwide have also forced organizations to re-examine and update their protocols to accommodate new compliance frameworks. The reliance on cloud solutions and integrated data platforms has improved visibility into supply chain performance, leading to shorter lead times and a reduction in operational waste. Furthermore, the push for sustainability and ethical practices has initiated a dialogue around the environmental impact of logistics. In addition to enhanced efficiency and cost management, stakeholders are now also evaluating how to best address environmental concerns without compromising on the quality and timeliness of clinical supplies.
These transformative shifts are not only redefining operational benchmarks but also setting the stage for a more resilient, technology-driven future in clinical trial supply management.
Regional Trends Influencing Global Operations
The clinical trial supply and logistics ecosystem exhibits significant regional nuances that impact strategic decision-making. The Americas continue to be a robust market characterized by advanced regulatory frameworks, strong infrastructure, and a willingness to adopt innovative technologies. Observations in this region provide insight into high standards of operational performance and the ability to handle complex, large-scale trials.
In contrast, the Europe, Middle East & Africa region offers a mix of mature markets and emerging opportunities, influenced by diverse regulatory environments and varying degrees of technological adoption. The evolution in these regions underscores the need for tailored logistic solutions that can adapt to differing market maturity and healthcare priorities. The Asia-Pacific region, with its rapid economic growth and increasing investments in healthcare innovation, is emerging as a pivotal hub. This region’s fast-paced expansion and growing emphasis on quality and efficiency create fertile ground for innovations that bridge traditional practices with modern technological solutions.
These regional insights reveal how varying market dynamics and infrastructural developments continue to shape the global landscape of clinical trial supply and logistics, prompting stakeholders to consider localized strategies within a globally integrated framework.
Innovative Leadership: Key Companies Reshaping the Market
The dynamic nature of the clinical trial supply and logistics market is driven by a host of leading companies that are continuously pushing the boundaries of operational efficiency and technological integration. Prominent players such as Acnos Pharma GmbH and ADAllen Pharma Ltd are recognized for their specialized approaches in managing complex trial supplies. Organizations like Almac Group Limited and Ancillare, LP are redefining standards with their integrated supply solutions, while Avantor, Inc. and Beroe Holdings Inc. have become synonymous with robust logistical support in high-stakes environments.
The landscape is further enriched by innovators including Biocair International Limited, Calyx, and Catalent, Inc., whose services cater to a spectrum of clinical operations. Clinical Services International LTD and Clinigen Group PLC have consistently provided reliable and adaptive supply chain solutions that align with rapidly evolving trial protocols. COREX LOGISTICS LIMITED, DHL Group, and Eurofins Scientific SE are setting benchmarks in the transport and quality assurance domains, demonstrating their commitment to timely and secure supply chain management. The technological integration spearheaded by companies like Experic, LLC and FedEx Corporation has revolutionized end-to-end visibility.
The report delves into recent significant developments in the Clinical Trial Supply & Logistics Market, highlighting leading vendors and their innovative profiles. These include:
- Acnos Pharma GmbH
- ADAllen Pharma Ltd
- Almac Group Limited
- Ancillare, L.P.
- Avantor, Inc.
- Beroe Holdings Inc.
- Biocair International Limited
- Calyx
- Catalent, Inc.
- Clinical Services International LTD.
- Clinigen Group PLC
- COREX LOGISTICS LIMITED
- DHL Group
- Eurofins Scientific SE
- Experic, LLC
- FedEx Corporation
- ICON PLC
- Inceptua S.A.
- Infosys Limited
- IPS Pharma
- KLIFO A/S
- Lonza Group AG
- Marken Limited by United Parcel Service, Inc.
- Microsoft Corporation
- Myonex, Inc.
- N-SIDE SA
- NUVISAN GmbH
- OCT Clinical GmbH
- Octalsoft
- Parexel International Corporation
- PCI Pharma Services
- PHOENIX Pharmahandel GmbH & Co. KG
- Piramal Pharma Limited
- Recipharm AB
- SAP SE
- Sharp Services, LLC
- Signant Health
- SIRO Clinpharm Private Limited
- Thermo Fisher Scientific Inc.
- Tower Cold Chain Solutions
- Uniphar PLC
- Walden Group
- Zuellig Pharma Pte. Ltd. by Interpharma Investments Limited
Actionable Recommendations for Industry Leaders
Drawing from current trends and multifaceted market segmentation, industry leaders are encouraged to adopt multiple strategic initiatives. First, embracing integrated digital systems to streamline communications, ensure real-time tracking, and automate critical supply processes can significantly reduce lead times and enhance overall efficiency. It is advisable to invest in technologies that provide end-to-end visibility of supply chains, which can help preempt potential disruptions and ensure compliance with evolving regulatory requirements.
Leaders should also consider the benefits of flexible sourcing models. By evaluating the merits of centralized versus decentralized sourcing, organizations can design bespoke solutions that meet the specific demands of their trial phases. It is also crucial to fine-tune logistics strategies, especially in managing cold chain requirements versus conventional distribution, to cater to the unique needs of biologic drugs and other sensitive trial materials.
Moreover, industry innovators are advised to build collaborative relationships with key global partners. This cooperation not only fosters knowledge exchange but also enables co-development of advanced logistics solutions that accommodate regional variances. Strategic focus on training and development, coupled with investment in sustainable practices, can drive both operational excellence and environmental stewardship. These recommendations offer a roadmap for creating resilient supply chains that are capable of navigating the complexities of modern clinical trials, thereby securing a competitive edge in a rapidly evolving market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 196 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $26.2 Billion |
| Forecasted Market Value (USD) by 2030 | $41.04 Billion |
| Compound Annual Growth Rate | 7.7% |
| Regions Covered | Global |
Key Topics Covered
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Globalization of clinical trials and harmonization of regulations
5.1.1.2. Rising government funds to strengthen pharmaceutical R&D activities across economies with increasing incidence of chronic diseases
5.1.2. Restraints
5.1.2.1. Problems associated with technology integration and data management
5.1.3. Opportunities
5.1.3.1. Increasing partnership activities between pharmaceutical manufacturers and CDMOs
5.1.3.2. Integration of artificial intelligence and machine learning for predictive analytics in supply chain optimization
5.1.4. Challenges
5.1.4.1. Concerns associated with the operations within clinical trial supply and logistics
5.2. Market Segmentation Analysis
5.2.1. Services: Continuous advancements in cold chain distribution services with growing demand
5.2.2. Type: Surging utilization of small molecules in the pharmaceutical sector
5.2.3. Mode of Delivery: Growing adoption of offsite solutions for multi-site trials delivery
5.2.4. Sourcing Model: Rising demand for decentralized sourcing models to enhance the speed and efficiency of supply distribution
5.2.5. Phase: Increasing scope of supply & logistics services in phase 3 clinical trials
5.2.6. Therapeutic Area: Proliferating private and public sector investments and research activities in oncology
5.2.7. End User: Rising use of clinical trial supply & logistics by pharmaceutical & biotechnology companies
5.3. Porter’s Five Forces Analysis
5.4. PESTLE Analysis
6. Clinical Trial Supply & Logistics Market, by Services
6.1. Introduction
6.2. Comparator Sourcing
6.3. Logistics & Distribution
6.3.1. Cold Chain Distribution
6.3.2. Non-Cold Chain Distribution
6.4. Manufacturing
6.5. Packaging, Labeling, & Blinding
6.6. Storage & Retention
7. Clinical Trial Supply & Logistics Market, by Sourcing Model
7.1. Introduction
7.2. Centralized Sourcing
7.3. Decentralized Sourcing
8. Clinical Trial Supply & Logistics Market, by Type
8.1. Introduction
8.2. Biologic Drugs
8.3. Medical Devices
8.4. Small Molecules
9. Clinical Trial Supply & Logistics Market, by Mode of Delivery
9.1. Introduction
9.2. Offsite Supply Management
9.3. Onsite Supply Management
10. Clinical Trial Supply & Logistics Market, by End-user
10.1. Introduction
10.2. Contract Research Organisations
10.3. Medical Devices Companies
10.4. Pharmaceutical & Biotechnology Companies
11. Clinical Trial Supply & Logistics Market, by Therapeutic Area
11.1. Introduction
11.2. Blood Disorders
11.3. Cardiovascular Diseases
11.4. CNS & Mental Disorders
11.5. Dermatological Disorders
11.6. Digestive Disorders
11.7. ENT Diseases
11.8. Immunology
11.9. Infectious Diseases
11.10. Metabolic Disorders
11.11. Nephrology
11.12. Oncology
11.13. Rare Diseases
11.14. Respiratory Disorders
12. Clinical Trial Supply & Logistics Market, by Phases of Clinical Trials
12.1. Introduction
12.2. BA/ BE studies
12.3. Phase 1
12.4. Phase 2
12.5. Phase 3
12.6. Phase 4
13. Americas Clinical Trial Supply & Logistics Market
14. Asia-Pacific Clinical Trial Supply & Logistics Market
15. Europe, Middle East & Africa Clinical Trial Supply & Logistics Market
16. Competitive Landscape
16.1. Market Share Analysis, 2023
16.2. FPNV Positioning Matrix, 2023
16.3. Competitive Scenario Analysis
16.3.1. Catalent strengthens European supply chain with USD 25 million expansion of Schorndorf facility, enhancing FastChain capabilities
16.3.2. Experic strategically expands to Europe with a new Dublin facility enhancing global clinical trial supply and logistics services
16.3.3. FedEx fortifies its global clinical trial logistics with a new life science center in Mumbai, enhancing healthcare supply chain connectivity
16.3.4. PCM Trials acquires Netherlands-based clinical trial service
16.3.5. Piramal Pharma solutions commemorates opening of its ADC manufacturing expansion in Grangemouth, Scotland
16.3.6. Biocair announces the U.S. expansion as part Of global growth strategy
16.3.7. Vaxcyte and Lonza sign new commercial manufacturing agreement for PCVs
16.3.8. Piramal Pharma Solutions launches in-vitro biology capabilities at Ahmedabad discovery services site
16.3.9. Signant Health Launches Signant Biotech to accelerate and streamline clinical development for emerging biopharmaceutical organizations
16.3.10. N-SIDE introduces Lighthouse, innovative software to shape the future of worldwide clinical trial supply management
16.3.11. Zuellig Pharma and GSK establish a vaccine distribution hub in Singapore
16.3.12. Ariceum Therapeutics and Eurofins CDMO sign a pharmaceutical multi-project agreement
16.3.13. Vial announces strategic partnership with Royale International Group
16.3.14. Biocair partners with TrakCel to improve visibility in the supply chain
16.3.15. IDEAYA expands clinical trial collaboration and supply agreements with Pfizer
16.3.16. Calyx introduces new clinical trial supply forecasting service
16.3.17. Catalent completes expansion of Singapore clinical supply facility for increased temperature-controlled capabilities
16.4. Strategy Analysis & Recommendations
16.4.1. Almac Group Limited
16.4.2. Catalent, Inc.
16.4.3. DHL Group
16.4.4. Walden Group
For more information about this report visit https://www.researchandmarkets.com/r/csr6x6
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
- Clinical Trial Supply & Logistics Market
